The potential effects of dietary flavones on diabetic nephropathy; a review of mechanisms
Autor: | Amirhosein Meisami, Lida Menati, Mitra Zarebavani |
---|---|
Rok vydání: | 2020 |
Předmět: |
chemistry.chemical_classification
Kidney education.field_of_study business.industry Urology Population 030232 urology & nephrology Disease 030204 cardiovascular system & hematology Pharmacology medicine.disease medicine.disease_cause Flavones Nephropathy Diabetic nephropathy 03 medical and health sciences 0302 clinical medicine medicine.anatomical_structure chemistry Nephrology Diabetes mellitus medicine education business Oxidative stress |
Zdroj: | Journal of Renal Injury Prevention. 9:e09-e09 |
ISSN: | 2345-2781 |
DOI: | 10.34172/jrip.2020.09 |
Popis: | Diabetes as a chronic metabolic disorder affects the worldwide population with high incidence of morbidity and mortality. Different complications such as nephropathy, neuropathy, ocular diseases, and cardiovascular disease are common in patients with diabetes that threaten the patient’s lifestyle. Diabetic nephropathy (DN) usually is related to some major structural alterations in the kidney which characterized by generation of toxic reactive oxygen species (ROS) or inhibition of antioxidant systems in kidney tissue. Different natural agents have been introduced to be used as a complementary treatment to prevent diabetic kidney disease. Flavones (apigenin, luteolin, nobiletin and chrysin) as a subgroup of flavonoids are natural occurring substances which have several pharmacological activates, including antioxidant, antiapoptotic, anti-inflammatory, and anti-tumor efficacy. Recent evidence indicated that flavones may be effective for prevention and treatment of diabetes complications in experimental models. The present study was designed to review the relationship between flavones administration and diabetes and diabetic kidney disease by focusing on the possible molecular pathway. The findings indicate that flavones have protective effects against diabetic kidney disease by modulation of different pathways related to oxidative stress, inflammation, and apoptosis in animal models. Therefore, more clinical investigations are suggested to be conducted to find the protective effects of flavones in patients with diabetes. |
Databáze: | OpenAIRE |
Externí odkaz: |